[Epidemiologic studies on respiratory diseases in Płock. IV. Selected environmental factors and symptoms of chronic non-specific respiratory diseases].
Explore the source record for details and available documents.
Adult↗
SEARCH · PubMed Health
Results for “RESPIRATORY DISEASES”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Primary care role in preventing occupational and environmental respiratory disease.
Occupational and environmental respiratory disease is relatively common and is usually of great significance for the individual and the broader community. With proper evaluation of both the individual and the exposure site, a specific diagnosis can be established or ruled out during the early stages. Primary care physicians are vital for the early diagnosis of occupational and environmental respiratory disease in individual patients and in populations. Furthermore, primary care practitioners may have a significant role in formal group-based medical surveillance programs for respiratory disease. In addition to diagnosing and treating such disorders, there is a major role for rational and effective counseling of individuals and communities about possible effects of agents ranging from air pollution to zeroconium. In such instances, objective data communicated in language that is easily understood can be invaluable.
Asbestos↗
Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression.
In summary, these findings indicate the importance of designing future experiments that delineate between opioid and nonopioid forms of respiratory disease and dysfunction, and the need to identify means of diagnosing them in order to achieve successful recovery. Apparently there is great diversity between animal species in terms of contributions of endogenous opioids to tonic control of ventilation, and future work should strive to identify which species is most appropriate as a model of human ventilatory control and disease. Certain opioid receptor types appear to be linked to independent respiratory functions. For instance, mu receptors in the brain stem produce strong inhibitory actions on respiratory parameters, including RR, VT, VE, and CO2 sensitivity. These effects have been observed in vivo and by electrophysiologic recordings in vitro. Delta receptors may also exert some inhibitory effect on respiration, especially in the NTS. In the CNS, the ventral surfaces of the medulla and pons, especially the NTS and NA, seem to be important sites for opioid-induced inhibition of respiration, whereas the spinal cord probably is not involved in opioid-mediated ventilatory depression. Kappa receptors appear to be devoid of respiratory depressant activity, whereas sigma receptors may stimulate some ventilatory parameters. Morphine and similar pure mu agonists, such as fentanyl and oxymorphine, probably produce their analgesic and respiratory depressant effects through stimulation of mu receptors. Mixed agonists/antagonists that have mu antagonist (or partial agonist) activity plus kappa agonist and/or sigma agonist activity show a ceiling effect for respiratory depression. Future tests need to determine which opioid receptor may be responsible for the ceiling effect. In addition, the effects of mu, delta, kappa, and sigma selective agonists on hypoxic drive should also be determined, as a drug that stimulates hypoxic sensitivity in the face of hypercapnic depression may produce less overall respiratory depression due to counteractive effects. In the future, clinically optimal opiates should have more specificity of action than those available now. This may be achieved by creating drugs selective for single receptors or by creating drugs with desirable combinations of receptor selectivities. The combinations of mixed agonists/antagonists with pure mu agonists currently in use today are promising, as they provide analgesia with reduced respiratory depression. In the early days of opiate research and development, combination drug regimens were thoroughly tested to determine the "ideal ratios" that would retain analgesic properties but not the other undesirable effects such as respiratory depression (196).(ABSTRACT TRUNCATED AT 400 WORDS)
Animals↗
[Chronic respiratory disease and gastroesophageal reflux].
Both GERD(gastroesophageal reflux disease) and chronic respiratory disease are common disease in old and the association between GERD and chronic respiratory disease are recently proved in many reports. Patient with GERD have a higher prevalence of asthma and chronic cough. Aggressive antireflux therapy in patient with asthma and GERD results in improvement in asthma outcome. In our study, endoscopic examination revealed that the prevalence of esophageal mucosal disease in patient with asthma was about 83%. In this paper, I review the role of GERD in chronic respiratory disease, especially asthma.
Asthma↗
Air pollution and reversible chronic respiratory diseases.
Air pollution is one of the world's most serious environmental problems. It has been common knowledge for many years now that the lung is one of the main target organs of environmental agents. Over the last ten years, in particular, lung diseases have increased dramatically and the literature on the subject reports high death rates from lung cancer and an increased incidence of bronchial asthma and chronic obstructive pulmonary disease (COPD). These respiratory diseases are also caused by exposure to environmental agents, especially air pollution. Outdoor pollution is related to many compounds and, in assessing the air-borne pollutants and their association with respiratory damage, the role of particulate matter (PM) is of major importance. In addition to outdoor pollution, indoor pollution also exists and consists of environmental substances usually found outside which enter the internal environment, and/or of locally produced substances. Air pollution exposure involves the contact of pollutants with the respiratory tract, such exposure being measured according to two parameters: intensity and duration. Generally speaking, the pathogenic effects of environmental pollution on the organism fall into two categories: acute, or short-term effects, and long-term effects, depending on the time required from exposure to the manifestation of its effect. Short-term effects consist of irritant symptoms affecting the airways with different degrees of severity, while long-term effects, related to chronic exposure, are associated with chronic respiratory diseases, and unremitting symptoms such as coughing, wheezing, etc. Moreover, air irritants can give rise to inflammatory damage of the mucous membrane of the airways, thereby making it more susceptible to various types of allergens. In conclusion, air pollution is an important etiological factor for many chronic respiratory disorders, such as bronchial asthma and COPD. Prevention programs and early treatments are essential in an attempt to block the clinical-functional deterioration caused by these respiratory diseases.
Air Pollutants↗
Vaccines for respiratory disease in cattle.
Respiratory disease is one of the most serious disease complexes affecting beef cattle production. For example, it is claimed to cost the UK industry about 70 million pounds per year. It is usually associated with young cattle and can occur in a variety of situations. It is a good example of multifactorial disease in that its aetiology involves both infection by a variety of microorganisms and a number of environmental factors. Several distinct syndromes occur and a number of microorganisms are thought to be important including the bacteria Pasteurella haemolytica type A1, P. multocida, Haemophilus somnus, Corynebacterium pyogenes, Mycoplasma bovis and M. dispar. Of the viruses, bovine herpes virus 1 (BHV1) and respiratory syncytial virus (RSV) are known to be important, the former also causing the specific syndrome, infectious bovine rhinotracheitis (IBR) in addition to its involvement in the pneumonia complex. Other viruses of possible importance include para-influenza 3 (Pi3), adenoviruses, bovine viral diarrhoea (BVD) virus, coronavirus and rhinovirus.
Animals↗
EPIDEMIOLOGY AND PREVENTION OF ACUTE RESPIRATORY DISEASE IN NAVAL RECRUITS. I. TEN YEARS' EXPERIENCE WITH MICROBIAL AGENTS ISOLATED FROM NAVAL RECRUITS WITH ACUTE RESPIRATORY DISEASE.
Explore the source record for details and available documents.
Adenoviridae Infections↗
THE CHILLIWACK RESPIRATORY SURVEY, 1963. IV. THE EFFECT OF TOBACCO SMOKING ON THE PREVALENCE OF RESPIRATORY DISEASE.
Chronic non-specific respiratory disease was found by a survey at Chilliwack, B.C., to affect 29.3% of men and 18.0% of women between the ages of 25 and 74. The habit of current cigarette smoking was found to be the most important single factor associated with respiratory disease, and was found to be related to changes in simple measures of lung function. The authors were unable to confirm the existence of a threshold in lifetime cigarette smoking before respiratory disease occurred.Comparisons were made with a population previously studied at Berlin, New Hampshire, U.S.A., in 1961. At Berlin, where pollution by SO(2) and dust-fall had been thoroughly documented, the comparable prevalence rates for respiratory disease were 40.0% for men and 21.6% for women. When differences between the two populations as to age and number of cigarettes smoked daily were taken into account, the disease rates in these two communities were found to be quite similar. The Chilliwack sample did, however, have significantly higher values for the lung function tests.
Berlin↗
Occupational respiratory diseases.
The respiratory tract is often the site of injury from occupational exposures because it has direct contact with the ambient environment. Inhalation of potentially toxic materials in the workplace can lead to all major lung diseases with the exception of pulmonary vascular ones. New materials are being introduced into the workplace at a rate faster than their potential toxicities can be evaluated, and some are found to cause lung disease. Therefore, the possibility of occupational lung disease should be considered whenever a working or retired person has unexplained respiratory illness.
Diagnostic Techniques, Respiratory System↗
Protection against respiratory disease in calves induced by vaccines containing respiratory syncytial virus, parainfluenza type 3 virus, Mycoplasma bovis and M dispar.
A field trial to assess the ability of two vaccines to protect calves against respiratory disease was carried out on a large beef rearing unit in southern England over the two winters of 1983 to 1984 and 1984 to 1985. A quadrivalent vaccine containing the killed antigens of respiratory syncytial virus, parainfluenza virus type 3, Mycoplasma bovis and M dispar or a vaccine containing only the respiratory syncytial virus component were inoculated into 246 and 245 calves, respectively; 245 calves remained as unvaccinated controls. The calves were reared in seven batches and outbreaks of disease occurred in five; significant protection was achieved in the four batches in which disease was associated with respiratory syncytial virus and M bovis infection, together or independently. The death rate from pneumonia was 9 per cent in the control group, 2 per cent in the calves inoculated with the quadrivalent vaccine (P less than 0.001), a protection rate of 77 per cent, and 3 per cent in the calves inoculated with the respiratory syncytial virus vaccine (P less than 0.01), a protection rate of 68 per cent. The proportion of calves receiving treatment for respiratory disease was 38 per cent in the control group, 25 per cent in the calves inoculated with the quadrivalent vaccine (P less than 0.001) and 27 per cent in the calves inoculated with the respiratory syncytial virus vaccine (P less than 0.01). The results show that protection against respiratory disease can be achieved by parenteral vaccination of calves with the appropriate inactivated microorganisms.
Animals↗
[Commonly observed diseases in newborn infants. Respiratory diseases].
Explore the source record for details and available documents.
Humans↗
Neurologic complications of respiratory disease.
The respiratory system and the central nervous system are interconnected in a delicate balance; disorders in this equilibrium can have devastating consequences. Respiratory dysfunction, whether acute or chronic, may cause neurologic disease, including headache, encephalopathy, and in extreme cases, coma and death. This article will discuss abnormalities in ventilation and gas exchange, their subsequent pathophysiologic effects on the nervous system, and mechanisms of treatment for these disorders.
Humans↗
Mycoplasmas associated with canine infectious respiratory disease.
Canine infectious respiratory disease (CIRD) is a complex infection that occurs worldwide predominantly in kennelled dogs, and several bacterial and viral micro-organisms have been associated with outbreaks of CIRD. However, few studies have comprehensively examined the species of mycoplasma present in healthy dogs and those with CIRD. As part of an extensive study investigating the micro-organisms involved in CIRD, the species of mycoplasma present throughout the respiratory tract of dogs with and without CIRD were determined. Mycoplasmas were cultured from tonsillar, tracheal and bronchial lavage samples, and identified to the species level by PCR and sequencing. Mycoplasma cynos was demonstrated on the ciliated tracheal epithelium by in situ hybridization and was the only mollicute found to be associated with CIRD, but only in the lower respiratory tract. Isolation of M. cynos was correlated with an increased severity of CIRD, younger age and a longer time in the kennel.
Animals↗
Pathogenesis of aspirin-exacerbated respiratory disease.
The underlying respiratory disease is activated by unknown mechanism and results in an intense infiltration of mast cells and eosinophils into the entire respiratory mucosa. These cells synthesize leukotrienes (LTs) at a very high rate and mast cells also release histamine and tryptase and synthesize PGD(2) a vasodilator and bronchoconstrictor. Furthermore, AERD patients under synthesize from arachidonic acid (AA) a peculiar product called lipoxins, which opposes inflammation generated by leukotrienes. Finally, cysLT1 receptors are over expressed and highly responsive to LTE(4), further augmenting the underlying inflammatory disease. This inflammatory condition is partly inhibited by synthesis of PGE(2) through COX-1. PGE(2) partially inhibits 5-lipogygenase conversion of AA to LTA(4) and blocks release of histamine and tryptase from mast cells. When COX-l is inhibited by ASA or NSAIDs, PGE(2) synthesis stops and an enormous release of histamine and synthesis of LTs occurs. The upper respiratory reaction is mediated by both histamine and LTs but the bronchospastic reaction is mediated by LTs. The systemic effects of flush, gastric pain and hives are mediated by histamine. Aspirin desensitization can not be explained by disappearance of LT synthesis since urine LTE(4) levels are still elevated at acute ASA desensitization. However, mast cell products such as histamine, tryptase and PGD(2) are no longer released or synthesized at acute desensitization. It is more likely that a diminution in number or function of cysLT receptors accounts for the diminished inflammatory response found in ASA desensitization.
Anti-Inflammatory Agents, Non-Steroidal↗
Specialized nutritional support in respiratory disease.
Nutritional status in patients with respiratory disease is discussed and nutritional support and pharmacotherapy considerations in these patients are reviewed. Undernutrition is common among patients with respiratory disease and can lead to decreased respiratory muscle mass and ventilatory drive. Both overfeeding and underfeeding can adversely affect patient outcome. Specialized nutrition-support regimens for patients with respiratory disease should include carbohydrate doses below the maximal oxidative rates for glucose and fat emulsion as a daily continuous infusion. Early enteral feeding may be beneficial. Respiratory quotient, oxygen consumption, and carbon dioxide production are useful measurements in providing optimal nutrition support. Pharmacotherapeutic measures, such as gastrointestinal-tract decontamination and growth-hormone administration, are being investigated in these patients as adjunctive therapy. Nutrition-support regimens for patients with respiratory disease should be carefully designed and monitored to avoid further compromising respiratory function and to reduce the risk of infection.
Enteral Nutrition↗
Relationship between serum immunoglobulin values and incidence of respiratory disease in calves.
Severe respiratory disease, with high morbidity and high mortality, occurred in 2 groups of bull calves (14 to 64 days old) raised in th same facility. Necropsy findings included lesions of acute or chronic bronchopneumonia. Serum immunoglobulin G (IgG) values were determined for all calves at 3 to 6 days of age. Calves that died of respiratory disease had an average IgG value of 1,267 mg/100 ml, whereas calves that lived had an average IgG value of 2,698 mg/100 ml. Calves with low serum IgG values had higher morbidity, had to be treated earlier in life, and had to be treated more frequently per day, when compared with calves that had high serum IgG values.
Animals↗
Influence of breed, heterozygosity, and disease incidence on estimates of variance components of respiratory disease in preweaned beef calves.
The objective of this study was to characterize genetic and environmental factors influencing bovine respiratory disease (BRD) in beef cattle. Records from nine purebred and three composite breeds and a variety of F1 and three-way crosses, including the progeny of 12 additional different sire breeds produced over a 20-yr period (1983 to 2002), were evaluated for breed and heterozygosity effects on the observed incidence of BRD. Heterozygosity fractions for calves and dams were defined by generalized breed origins: British, Continental, and tropically adapted. Variance components were estimated for each pure and composite breed, and across all breeds and crossbreeds. The effect of incidence of observed BRD was determined by comparing groups of low and high years of incidence. Respiratory disease in this herd followed a standard epidemiological pattern of initial introduction, reaching an epidemic stage at 70 to 170 d of age, followed by a period of rapid decrease to weaning. Estimates of heritability of incidence of BRD were low, ranging from 0.00 to 0.26, with overall estimates of 0.07 and 0.19 depending on the data set analyzed. The highest incidence of BRD in preweaned calves occurred in the Braunvieh breed (18.8%). The genetic correlation between the direct and maternal genetic effects was generally large and negative, suggesting dams genetically superior for resisting BRD raise calves that are more susceptible. Perhaps maternally superior dams provide passive immunity to their calves, which delays the development of the calves' direct immune system, making them more prone to BRD during the preweaning period. Heterozygosity of calves decreased the incidence of BRD compared with purebred cattle. Calves that were Continental x British or tropically adapted x British breeds had a lower incidence of BRD than did calves of British x British breeds. As the annual incidence of BRD increased, there was an associated increase in the heritability estimate. The estimated heritability based on an underlying continuous scale was large (h2 = 0.48), inferring response to selection for BRD resistance could be large if the phenotype for BRD resistance was known.
Age Factors↗
Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus.
The prevalence of bovine viral diarrhea virus (BVDV) infections was determined in a group of stocker calves suffering from acute respiratory disease. The calves were assembled after purchase from Tennessee auctions and transported to western Texas. Of the 120 calves, 105 (87.5%) were treated for respiratory disease. Sixteen calves died during the study (13.3%). The calves received a modified live virus BHV-1 vaccine on day 0 of the study. During the study, approximately 5 wk in duration, sera from the cattle, collected at weekly intervals, were tested for BVDV by cell culture. Sera were also tested for neutralizing antibodies to BVDV types 1 and 2, bovine herpesvirus-1 (BHV-1), parainfluenza-3 virus (PI-3V), and bovine respiratory syncytial virus (BRSV). The lungs from the 16 calves that died during the study were collected and examined by histopathology, and lung homogenates were inoculated onto cell cultures for virus isolation. There were no calves persistently infected with BVDV detected in the study, as no animals were viremic on day 0, nor were any animals viremic at the 2 subsequent serum collections. There were, however, 4 animals with BVDV type 1 noncytopathic (NCP) strains in the sera from subsequent collections. Viruses were isolated from 9 lungs: 7 with PI-3V, 1 with NCP BVDV type 1, and 1 with both BVHV-1 and BVDV. The predominant bacterial species isolated from these lungs was Pasteurella haemolytica serotype 1. There was serologic evidence of infection with BVDV types 1 and 2, PI-3V, and BRSV, as noted by seroconversion (> or = 4-fold rise in antibody titer) in day 0 to day 34 samples collected from the 104 survivors: 40/104 (38.5%) to BVDV type 1; 29/104 (27.9%) to BVDV type 2; 71/104 (68.3%) to PI-3V; and 81/104 (77.9%) to BRSV. In several cases, the BVDV type 2 antibody titers may have been due to crossreacting BVDV type 1 antibodies; however, in 7 calves the BVDV type 2 antibodies were higher, indicating BVDV type 2 infection. At the outset of the study, the 120 calves were at risk (susceptible to viral infections) on day 0 because they were seronegative to the viruses: 98/120 (81.7%), < 1:4 to BVDV type 1; 104/120 (86.7%) < 1:4 to BVDV type 2; 86/120 (71.7%) < 1:4 to PI-3V; 87/120 (72.5%) < 1:4 to BRSV; and 111/120 (92.5%) < 1:10 to BHV-1. The results of this study indicate that BVDV types 1 and 2 are involved in acute respiratory disease of calves with pneumonic pasteurellosis. The BVDV may be detected by virus isolation from sera and/or lung tissues and by serology. The BVDV infections occurred in conjunction with infections by other viruses associated with respiratory disease, namely, PI-3V and BRSV. These other viruses may occur singly or in combination with each other. Also, the study indicates that purchased calves may be highly susceptible, after weaning, to infections by BHV-1, BVDV types 1 and 2, PI-3V, and BRSV early in the marketing channel.
Animals↗